Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer

This study investigated the maximum tolerated dose (MTD) of S-1 with concurrent radiotherapy in patients with head and neck cancer, based on the frequency of dose-limiting toxicities (DLT). S-1 was administered orally at escalating doses from 40 mg/m(2) b.i.d. on the days of delivering radiotherapy,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Nakata, Kensei, Sakata, Koh-ichi, Someya, Masanori, Miura, Katsutoshi, Hayashi, Junichi, Hori, Masakazu, Takagi, Masaru, Himi, Tetsuo, Kondo, Atsushi, Hareyama, Masato
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2013
Onderwerpen:
Oncology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3709662/
https://ncbi.nlm.nih.gov/pubmed/23292146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jrr/rrs133
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items